Send password reminder...
Subscribe to New Research on HBY 097
a quinoxaline derivative
Also Known As:
relevant articles (
Bio-Agent Context: Research Results
Heterocyclic Compounds: 60
2-Ring Heterocyclic Compounds
HBY 097: 2
Drug Toxicity (Drug Safety)
03/01/1998 - "
Both procedures were applied to the quantitation of HBY 097 and its metabolites in serum and urine of HIV positive patients who were enrolled in a clinical study of drug safety and pharmacokinetics.
11/27/1998 - "
The second generation Hoechst-Bayer non-nucleoside inhibitor, HBY 097 (S-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3, 4-dihydroqui noxalin-2(1H)-thione), is an extremely potent inhibitor of HIV-1 reverse transcriptase (RT) and of HIV-1 infection in cell culture.
Related Drugs and Biologics
Human immunodeficiency virus 1 reverse transcriptase
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
We wish to acknowledge and thank the US National Library of Medicine and Medline staff for providing access to their data.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.